Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious ...

Health experts are warning of a potential 'tripledemic' this winter - here's how to spot the early symptoms of flu, RSV and ...

The NHS has listed the symptoms of covid, RSV and flu to help you tell the difference between each one, as cases forecast to ...

A new study shows that the addition of respiratory syncytial virus (RSV) to Minnesota’s viral genomic surveillance program ...

Each year, 100,000 older US adults and 58,000 infants and children younger than 5 years are hospitalized for RSV, and 6,000 ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

The term “immunity debt” is being used to describe how countries are seeing an increase in viral infections, particularly ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

RSV vaccination was associated with decreased risks for infection and hospitalization, although the decrease was not statistically significant.

Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...